Top Mid-Cap Performers of the Week (October 28 - November 1)
Shares of Madrigal Pharmaceuticals soared 51.70% after the company announced positive results from a Phase 3 trial of its drug resmetirom for non-alcoholic steatohepatitis (NASH). The drug met the primary endpoint of the trial, showing a significant reduction in liver fibrosis without worsening NASH.
PROCEPT BioRobotics shares jumped 34.20% following a strong third-quarter earnings report and an increase in the company's FY24 revenue guidance. Additionally, the company successfully priced a $175 million offering of its common stock, further boosting investor confidence.
Globalstar stock climbed 33.98% after the company announced an amendment to its services agreement with Apple. This agreement will see Globalstar launch an expanded Mobile Satellite Service (MSS) network with new satellites and infrastructure, potentially positioning the company for significant growth.
GeneDx shares surged 31.17% on the back of better-than-expected earnings and an upward revision of the company's FY24 revenue guidance. Several analysts also raised their price targets on the stock, contributing to the positive sentiment.
NEXTracker shares rose 25.91% after the company reported strong second-quarter results and raised its FY25 GAAP and adjusted EPS guidance. This positive outlook and exceeding expectations fueled investor optimism.
V.F. Corporation stock gained 25.82% following the release of its second-quarter financial results. The company's performance exceeded analyst expectations, and several analysts subsequently raised their price targets, leading to the stock's surge.
Omnicell stock climbed 23.22% after the company reported strong third-quarter results and raised its FY24 guidance above estimates. This positive performance and exceeding expectations led analysts to increase their price targets on the stock, further driving its upward movement.